Literature DB >> 27422969

Endovascular treatment in the acute and non-acute phases of carotid dissection: a therapeutic approach.

Fernando Delgado1, Isabel Bravo1, Elvira Jiménez1, Eduardo Murías2, Antonio Saiz3, Pedro Vega2, Antonio López-Rueda4, Jordi Blasco4, Juan Macho4, Alejandro González5.   

Abstract

BACKGROUND: Carotid dissection (CD) may, in certain cases, lead to significant stenosis, occlusion, or pseudoaneurysm formation, causing embolic stroke or hemodynamic failure, despite medical therapy.
OBJECTIVE: To evaluate the results of endovascular treatment and clinical outcomes of patients with CD.
METHODS: A four-hospital retrospective study of endovascular treatment of extracranial CD in which medical treatment had failed or patients presented with a National Institute of Health Stroke Scale (NIHSS) score ≥8.
RESULTS: Thirty-eight patients (mean age 46.6±13.5 years, 78.9% male, 84.2% spontaneous CD, 44.7% left CD and 26.3% bilateral CD) were analyzed. In 24 patients (63.2%) treatment was undertaken in the acute-phase CD (APCD). IV recombinant tissue plasminogen activator was administered in 7 (29.2%) APCD cases. The patients with APCD exhibited a high rate of successful revascularization (Thrombolysis In Cerebral Infarction ≥2b; 19 patients (79.2%)), a low risk of symptomatic intracranial hemorrhage (n=2 (8.3%)), and good global functional outcomes (modified Rankin Scale (mRS) ≤2; n=17 (70.8%)). Good recanalization correlated (p=0.001) with good clinical evolution (mRS ≤2) in the patients with APCD. Of the 14 patients with non-acute phase CD (NAPCD), seven were treated for pseudoaneurysm with multiple stents (six patients) or covered prostheses, with stenosis being treated in the remaining seven patients.
CONCLUSIONS: Endovascular treatment of selected cases of patients with CD associated with thromboembolic events and hemodynamic failure after unsuccessful medical therapy is a safe and effective method of restoring vessel lumen integrity, with good short-term clinical evolution. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Dissection; Stroke

Mesh:

Substances:

Year:  2016        PMID: 27422969     DOI: 10.1136/neurintsurg-2016-012475

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  3 in total

Review 1.  Endovascular Considerations in Traumatic Injury of the Carotid and Vertebral Arteries.

Authors:  Ananth K Vellimana; Jayson Lavie; Arindam Rano Chatterjee
Journal:  Semin Intervent Radiol       Date:  2021-04-15       Impact factor: 1.513

2.  Long-Term Outcomes of Stenting on Non-Acute Phase Extracranial Supra-Aortic Dissections.

Authors:  Yeqing Jiang; Ruoyu Di; Gang Lu; Lei Huang; Hailin Wan; Liang Ge; Xiaolong Zhang
Journal:  J Korean Neurosurg Soc       Date:  2022-04-25

3.  Clinical Outcomes of Endovascular Treatment for Carotid Artery Dissection Without Intracranial Large Vessel Occlusion in Patients With Cerebral Ischemia Presentation.

Authors:  Joong-Goo Kim; Chul-Hoo Kang; Jay Chol Choi; Yunsun Song; Dae Chul Suh; Deok Hee Lee
Journal:  Front Neurol       Date:  2022-02-02       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.